ArticleJournal of clinical medicine2022
Functional and Radiological Outcomes after Treatment with Custom-Made Glenoid Components in Revision Reverse Shoulder Arthroplasty.
Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 25 citations in OpenAlex.
- Clinical and radiological results of custom-made glenoid implants in reverse total shoulder arthroplasty with a mean follow-up of 36 months.Journal of shoulder and elbow arthroplasty · 2026Article
- Biomechanics of custom glenoid components in reverse total shoulder arthroplasty-a narrative review of concepts for surgeons.JSES reviews, reports, and techniques · 2026Review
- Survivorship, complications, and outcomes of custom glenoid implants in reverse total shoulder arthroplasty: a systematic review.JSES reviews, reports, and techniques · 2025Review
- Primary and Revision Reverse Shoulder Arthroplasty Using Custom-Made 3D-Printed Baseplates for Severe Multiplanar Glenoid Bone Defects: A Retrospective Study of Clinical and Radiographic Outcomes.Journal of clinical medicine · 2025Article
- A review of patient matched implants for shoulder arthroplasty.JSES international · 2025Review
- Current concepts in patient specific implants for reverse shoulder arthroplasty.JSES international · 2025Review
- Article
- Impact of transdermal buprenorphine patch combined with celecoxib on improving shoulder pain and function of patients with primary adhesive shoulder capsulitis.BMC musculoskeletal disorders · 2024Observational
- Early results of reverse total shoulder arthroplasty using a patient-specific baseplate to address severe glenoid deficiency.Shoulder & elbow · 2024Article
- Patient-specific implants in reverse shoulder arthroplasty.Clinics in shoulder and elbow · 2024Article
- The Evolution of Reverse Total Shoulder Arthroplasty-Where Do We Stand and What Comes Next?Journal of clinical medicine · 2023Article
- A review of custom implants for glenoid bone deficiency in reverse shoulder arthroplasty.Journal of orthopaedics · 2023Review
- Clinical and Radiological Outcomes after Total Shoulder Arthroplasty Using Custom-Made Glenoid Components: A Systematic Review.Journal of clinical medicine · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Glenoid implant position and fixation are challenging in severe glenoid defects in reverse total shoulder arthroplasty (rTSA). Custom-made glenoid implants are metal augmented implants that are specially produced for a certain defect. They provide the restoration of the joint line and proper fixation. This retrospective data analysis investigated the clinical and radiological outcomes after revision using custom-made glenoid implants. Between 2018 and 2020, nine patients (10 shoulders) with severe glenoid defects underwent revision rTSA using a custom-made glenoid implant (Materialise Glenius or Lima ProMade). The pre- and postoperative Constant Murley Score (CMS), UCLA Score and Subjective Shoulder Value (SSV) were assessed. Postoperative CT scans and X-rays in two planes were available. The minimum follow-up was 12 months, with a mean follow-up of 23.1 months. The mean preoperative CMS, UCLA Score and SSV were 10.9, 4.1 and 11.0, respectively. The mean postoperative CMS, UCLA Score and SSV showed significant increases of 51.7 (<0.001), 22.9 (<0.001) and 52.0 (<0.001), respectively. There were no signs of loosening implants or scapular notching, and no revision was necessary. This trial showed promising clinical and radiological short-term outcomes for custom-made glenoid components in revision rTSA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.